Search Results - "TYKOCINSKI, Mark L"

Refine Results
  1. 1

    Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer by Greene, Mark I, Furuuchi, Keiji, Kojima, Yoshitsugu, Tone, Yukiko, Tone, Masahide, Tykocinski, Mark L

    Published in Nature immunology (01-02-2008)
    “…The transcription factor Foxp3 is involved in the differentiation, function and survival of CD4 + CD25 + regulatory T (T reg ) cells. Details of the mechanism…”
    Get full text
    Journal Article
  2. 2

    Energy transfer in "parasitic" cancer metabolism: Mitochondria are the powerhouse and Achilles' heel of tumor cells by Martinez-Outschoorn, Ubaldo E., Pestell, Richard G., Howell, Anthony, Tykocinski, Mark L., Nagajyothi, Fnu, Machado, Fabiana S., Tanowitz, Herbert B., Sotgia, Federica, Lisanti, Michael P.

    Published in Cell cycle (Georgetown, Tex.) (15-12-2011)
    “…It is now widely recognized that the tumor microenvironment promotes cancer cell growth and metastasis via changes in cytokine secretion and extracellular…”
    Get full text
    Journal Article
  3. 3

    Can Empathy, Other Personality Attributes, and Level of Positive Social Influence in Medical School Identify Potential Leaders in Medicine? by Hojat, Mohammadreza, Michalec, Barret, Veloski, J Jon, Tykocinski, Mark L

    Published in Academic medicine (01-04-2015)
    “…PURPOSETo test the hypotheses that medical students recognized by peers as the most positive social influencers would score (1) high on measures of engaging…”
    Get full text
    Journal Article
  4. 4

    Virchow at 200 and Lown at 100 — Physicians as Activists by Mangione, Salvatore, Tykocinski, Mark L

    Published in The New England journal of medicine (22-07-2021)
    “…The Covid-19 pandemic has forced many people to reconsider what medicine is all about. But debate over what doctoring is — and what it is not — is nothing new,…”
    Get full text
    Journal Article
  5. 5

    Fn14•TRAIL effectively inhibits hepatocellular carcinoma growth by Aronin, Alexandra, Amsili, Shira, Prigozhina, Tatyana B, Tzdaka, Kobi, Rachmilewitz, Jacob, Shani, Noam, Tykocinski, Mark L, Dranitzki Elhalel, Michal

    Published in PloS one (10-10-2013)
    “…New strategies for the treatment of hepatocellular carcinoma (HCC) are needed, given that currently available chemotherapeutics are inefficient. Since tumor…”
    Get full text
    Journal Article
  6. 6

    Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14 by Ochanuna, Zohar, Geiger-Maor, Anat, Dembinsky-Vaknin, Adi, Karussis, Dimitrios, Tykocinski, Mark L, Rachmilewitz, Jacob

    Published in PloS one (23-09-2010)
    “…T-helper polarization of naïve T cells is determined by a complex mechanism that involves many factors, eventually leading to activation of Th1, Th2, or Th17…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Negative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45 by Rachmilewitz, Jacob, Borovsky, Zipora, Riely, Gregory J., Miller, Robin, Tykocinski, Mark L.

    Published in The Journal of biological chemistry (18-04-2003)
    “…CD45 is the major protein tyrosine phosphatase receptor on T cell surfaces that functions as both a positive and a negative regulator of T cell receptor (TCR)…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Identifying potential engaging leaders within medical education: The role of positive influence on peers by Michalec, Barret, Veloski, J. Jon, Hojat, Mohammadreza, Tykocinski, Mark L.

    Published in Medical teacher (01-07-2015)
    “…Background: Previous research has paid little to no attention towards exploring methods of identifying existing medical student leaders. Aim: Focusing on the…”
    Get full text
    Journal Article
  12. 12

    CTLA-4·Ig converts naive CD4+CD25− T cells into CD4+CD25+ regulatory T cells by Razmara, Marjaneh, Hilliard, Brendan, Ziarani, Azadeh K., Chen, Youhai H., Tykocinski, Mark L.

    Published in International immunology (01-04-2008)
    “…CTLA-4·Ig was originally designed as an immunosuppressive agent capable of interfering with the co-stimulation of T cells. In the present study, we demonstrate…”
    Get full text
    Journal Article
  13. 13

    CTLA-4–Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells by Huang, Jui-Han, Tykocinski, Mark L.

    Published in International immunology (01-04-2001)
    “…Co-stimulator blockade and trans inhibitory signaling, using agents such as CTLA-4–Ig and Fas ligand (FasL) respectively have been invoked as alternative…”
    Get full text
    Journal Article
  14. 14

    CD40·FasL and CTLA-4·FasL Fusion Proteins Induce Apoptosis in Malignant Cell Lines by Dual Signaling by Orbach, Ariel, Rachmilewitz, Jacob, Shani, Noam, Isenberg, Yonatan, Parnas, Miriam, Huang, Jui-Han, Tykocinski, Mark L, Dranitzki-Elhalel, Michal

    Published in The American journal of pathology (01-12-2010)
    “…Evolution of apoptosis resistance in both lymphoma and leukemia cells is well documented, and induction of apoptosis in malignant cells is a major goal of…”
    Get full text
    Journal Article
  15. 15

    OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites by Tone, Yukiko, Kojima, Yoshitsugu, Furuuchi, Keiji, Brady, Maya, Yashiro-Ohtani, Yumi, Tykocinski, Mark L, Tone, Masahide

    Published in Journal of Immunology (01-08-2007)
    “…OX40 is a member of the TNFR superfamily (CD134; TNFRSF4) that is expressed on activated T cells and regulates T cell-mediated immune responses. In this study,…”
    Get full text
    Journal Article
  16. 16

    CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals by Orbach, Ariel, Rachmilewitz, Jacob, Parnas, Miram, Huang, Jui-Han, Tykocinski, Mark L, Dranitzki-Elhalel, Michael

    Published in The Journal of immunology (1950) (01-12-2007)
    “…The fusion protein CTLA-4 . FasL, a paradigmatic "trans signal converter protein", can attach to APC surfaces and in effect convert B7-activating costimulator…”
    Get full text
    Journal Article
  17. 17

    Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation by Moody, D. Branch, Briken, Volker, Cheng, Tan-Yun, Roura-Mir, Carme, Guy, Mark R, Geho, David H, Tykocinski, Mark L, Besra, Gurdyal S, Porcelli, Steven A

    Published in Nature immunology (01-05-2002)
    “…CD1 proteins present various glycolipid antigens to T cells, but the cellular mechanisms that control which particular glycolipids generate T cell responses…”
    Get full text
    Journal Article
  18. 18

    Fn14-TRAIL, a Chimeric Intercellular Signal Exchanger, Attenuates Experimental Autoimmune Encephalomyelitis by Razmara, Marjaneh, Hilliard, Brendan, Ziarani, Azadeh K, Murali, Ramachandran, Yellayi, Srikanth, Ghazanfar, Mustafa, Chen, Youhai H, Tykocinski, Mark L

    Published in The American journal of pathology (01-02-2009)
    “…Hallmarks of the pathogenesis of autoimmune encephalomyelitis include perivascular infiltration of inflammatory cells into the central nervous system,…”
    Get full text
    Journal Article
  19. 19

    Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 14 by Mishan-Eisenberg, Galit, Borovsky, Zipora, Weber, Matthew C, Gazit, Roi, Tykocinski, Mark L, Rachmilewitz, Jacob

    Published in The Journal of immunology (1950) (01-11-2004)
    “…The potency of TCR signaling during primary CD4+ T cell activation influences initial cytokine expression patterns and subsequent polarization toward either…”
    Get full text
    Journal Article
  20. 20

    CTLA-4 {middle dot} FasL Induces Alloantigen-Specific Hyporesponsiveness by Elhalel, Michal Dranitzki, Huang, Jui-Han, Schmidt, William, Rachmilewitz, Jacob, Tykocinski, Mark L

    Published in The Journal of immunology (1950) (15-06-2003)
    “…The APC:T cell interface can be effectively targeted with immunotherapeutic proteins. We previously described a unique trans signal converter protein, CTLA-4…”
    Get full text
    Journal Article